KCI wins injunction against Smith & Nephew in U.K.
This article was originally published in The Gray Sheet
Executive Summary
A U.K. patent court has entered an injunction against Smith & Nephew, prohibiting it from infringing on two Kinetic Concepts Inc. negative pressure wound therapy patents, though the injunction is stayed pending appeal. The court ruled in June that sales of Smith & Nephew's Renasys NPWT products infringe on two KCI patents. Smith & Nephew noted in a July 30 press release that the Renasys products will continue on the U.K. market pending an appeals court review. KCI, maker of the competing V.A.C. therapy products, won a related victory over Smith & Nephew in a recent U.S. lawsuit (1"The Gray Sheet" March 15, 2010)
You may also be interested in...
KCI Notches Partial Victory Against Smith & Nephew In German Patent Suit
Kinetic Concepts Inc. continued its string of patent victories against negative pressure wound therapy competitor Smith & Nephew in Germany last week, but the decision was more mixed than other recent rulings
KCI Wins Negative Pressure Wound Therapy Patent Suit Over Smith & Nephew
V.A.C. maker Kinetic Concepts claimed victory over Smith & Nephew in a long-standing negative pressure wound therapy patent infringement suit, but Smith & Nephew plans to appeal the verdict
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.